subscribe: Posts | Comments

UK breast surgeons withdraw lunchtime “quickie”

0 comments

Denise Turner
WVoN co-editor 

A treatment known as the ‘lunchtime boob job’ has been withdrawn after doctors found that tumours were more difficult to spot in the standard mammogram scans of women who had had it.

In one case, a 45-year-old nurse had her treatment for cancer delayed because the Macrolane gel masked the tumour.

The £2,500 procedure, offered by at least 65 clinics in Britain, claims to boost breasts by a cup size in a procedure lasting just 45 minutes.

Plastic surgeons in the UK welcomed the decision, after the British Association of Aesthetic Plastic Surgeons (BAAPS) found that 25% of their members had noticed complications as a result of the filler.

Its spokesman Fazel Fatah said that women injected with Macrolane should contact their GP to see if they should be referred for further screening.

He said:  “We have urged caution in the past against the use of fillers in the breast, especially when there is a lack of peer-reviewed results from controlled clinical trials.”

BAAPS had also expressed concerns regarding lump formation and capsular contracture – the hardening of breast tissue around the implant – as a result of using the gel.

Capsular contracture, which is serious and painful, happens as a result of the immune system (which normally defends the body’s integrity and health) attacking itself and can recur after the corrective surgery.

The Medicines and Healthcare products Regulatory Agency (MHRA) also thinks that the gel makes diagnosis difficult.

Cindy Wong, medical director of Swedish manufacturer Q-Med, sought to play down the safety issues saying:

“At present, there is a lack of consensus amongst radiologists regarding radiology examination of breasts treated with Macrolane.”

But she added: “We would urge women with Macrolane injections to tell their doctor before they have a mammogram so that they can be screened slightly differently. We recommend a mammogram and an ultrasound scan.”

Q-Med hopes to reintroduce the gel after further study.

Following the scandal surrounding the silicone breast implants manufactured by French company Poly Implant Prothese, Professor Sir Bruce Keogh, NHS medical director, is carrying out a review of cosmetic surgery, including fillers such as Macrolane.

Leave a Reply

Your email address will not be published. Required fields are marked *